z-logo
open-access-imgOpen Access
Five New Therapies or Just One New Treatment? A Critical Look at Immune Checkpoint Inhibition in Urothelial Cancer
Author(s) -
Amishi Y. Shah,
Jianjun Gao,
Arlene O. SiefkerRadtke
Publication year - 2017
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2017-0073
Subject(s) - durvalumab , avelumab , atezolizumab , nivolumab , medicine , immune checkpoint , pembrolizumab , cancer research , cancer , immune system , immunotherapy , oncology , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom